DEFINITIVE VS EXPLORATORY PERIODONTAL TRIALS - A SURVEY OF PUBLISHED STUDIES

被引:9
作者
HUJOEL, PP
机构
[1] Department of Dental Public Health Sciences, School of Dentistry, University of Washington, Seattle, Washington 98195
关键词
RANDOMIZED CONTROLLED TRIALS; PHASE III; EXPLORATORY TRIALS;
D O I
10.1177/00220345950740080401
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Definitive and exploratory randomized controlled trials (RCTs) have different goals as well as different design and analysis characteristics. The goal of definitive studies is to provide unequivocal evidence of a treatment's tangible benefit to the patient; a pre-trial-specified hypothesis is tested by use of a pre-trial-specified method. The goal of exploratory studies is to elucidate biological treatment mechanisms, to identify promising treatments, and to generate hypotheses for definitive studies; multiple hypotheses are evaluated to extract as much information from the data as possible. The purposes of this study were: (1) to survey selected design and analysis characteristics of randomized controlled periodontal trials published between 1988 and 1992 (n = 86), and (2) to classify trials as exploratory or definitive studies. The periodontal RCTs surveyed were typical of exploratory studies whose primary goal was to elucidate biological treatment mechanisms. Trial reports indicated the testing of multiple hypotheses (greater than or equal to 6 hypothesis tests in 70 of the 86 trials) on a variety of biological markers (86 out of 86 trials). The sample size (less than or equal to 30 subjects in 67 out of 86 trials), duration (less than or equal to 6 months in 65 out of 86 trials), and design and analysis characteristics (e.g., an absence of masking in 57 out of 86 trials) were also typical of exploratory studies which strive to obtain quick answers (short duration) at a low cost (small sample size; accept bias for increased efficiency and a lower cost). No definitive trials were identified. Promising, biologically active, treatments identified in exploratory trials should be evaluated in definitive studies where the primary goal is the procurement of unequivocal evidence of a treatment's tangible benefit to the patient. The costs and benefits of conducting definitive periodontal RCTs to provide such evidence should be investigated.
引用
收藏
页码:1453 / 1458
页数:6
相关论文
共 42 条
[1]  
BARDHAN KD, 1987, LANCET, V1, P1492
[2]   UNIVERSITY-INDUSTRY RESEARCH RELATIONSHIPS IN BIOTECHNOLOGY - IMPLICATIONS FOR THE UNIVERSITY [J].
BLUMENTHAL, D ;
GLUCK, M ;
LOUIS, KS ;
STOTO, MA ;
WISE, D .
SCIENCE, 1986, 232 (4756) :1361-1366
[3]   INDUSTRIAL SUPPORT OF UNIVERSITY-RESEARCH IN BIOTECHNOLOGY [J].
BLUMENTHAL, D ;
GLUCK, M ;
LOUIS, KS ;
WISE, D .
SCIENCE, 1986, 231 (4735) :242-246
[4]   SURROGATE END-POINTS - A BASIS FOR A RATIONAL APPROACH [J].
BOISSEL, JP ;
COLLET, JP ;
MOLEUR, P ;
HAUGH, M .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (03) :235-244
[5]  
BRODY BA, 1995, CLOT DISSOLVING DRUG
[6]  
CIANCIO SG, 1994, PERIODONTAL INSIGHTS, V1
[7]   HOW STUDY DESIGN AFFECTS OUTCOMES IN COMPARISONS OF THERAPY .1. MEDICAL [J].
COLDITZ, GA ;
MILLER, JN ;
MOSTELLER, F .
STATISTICS IN MEDICINE, 1989, 8 (04) :441-454
[8]   SURROGATE ENDPOINTS IN CLINICAL-TRIALS - CANCER [J].
ELLENBERG, SS ;
HAMILTON, JM .
STATISTICS IN MEDICINE, 1989, 8 (04) :405-413
[9]   SURROGATE END-POINTS [J].
ELLENBERG, SS .
BRITISH JOURNAL OF CANCER, 1993, 68 (03) :457-459
[10]  
Fleming T. R., 1992, STAT SCI, V7, P428